Blocking inflammation prevents cell death, improves memory in Alzheimer's disease

by University of California, IrvineA brain tissue sample from Kim Green’s study show microglia (red) and plaques (green). Credit: Green lab / UCIUsing a drug compound created to treat cance

Updated on: February 28,2024

Blocking inflammation prevents cell death, improves memory in Alzheimer's disease

by University of California, IrvineA brain tissue sample from Kim Green’s study show microglia (red) and plaques (green). Credit: Green lab / UCIUsing a drug compound created to treat cance

Updated on:February 28,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on: April 16,2024

Alzheimer's drug development pipeline: Promising therapies, pharma investment drive momentum in clinical trials

by University of Nevada, Las VegasAgents in clinical trials for treatment of Alzheimer's disease in 2023 (from ClinicalTrials.gov as of the index date of January 1, 2023). The inner ring show

Updated on:April 16,2024

Midlife insomnia may increase risk for later dementia

by Lori SolomonInsomnia and short sleep duration in middle age increase the risk for dementia, according to a study published in the September issue ofAge and Ageing.Xiao Tan, from the Zhejiang

Updated on: March 02,2024

Midlife insomnia may increase risk for later dementia

by Lori SolomonInsomnia and short sleep duration in middle age increase the risk for dementia, according to a study published in the September issue ofAge and Ageing.Xiao Tan, from the Zhejiang

Updated on:March 02,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on: March 02,2024

Researchers show multiple sclerosis drug can be used as Alzheimer's therapy

by Lindsay Travis,University of KentuckyWorking model for the effect of ponesimod on microglial activation and phagocytosis. Aβ42 binds to TLR4 and induces a complex with S1PR1. S1P co-activates

Updated on:March 02,2024

Mechanisms of phototherapy of Alzheimer's disease during sleep and wakefulness

by Frontiers JournalsPhotobiomodulation of brain cleansing of beta-amyloid during sleep. Credit: Frontiers JournalsPhotobiomodulation during sleep turns the brain into a washing machine, helping to cl

Updated on: March 02,2024

Mechanisms of phototherapy of Alzheimer's disease during sleep and wakefulness

by Frontiers JournalsPhotobiomodulation of brain cleansing of beta-amyloid during sleep. Credit: Frontiers JournalsPhotobiomodulation during sleep turns the brain into a washing machine, helping to cl

Updated on:March 02,2024

Autophagy malfunction study moves a step closer to understanding Rett syndrome

Updated on: April 17,2025

Autophagy malfunction study moves a step closer to understanding Rett syndrome

Updated on:April 17,2025

Dementia may reduce likelihood of a 'good death' for patients with cancer

by WileyCredit: CC0 Public DomainAs the population ages, the number of cancer patients with dementia has increased. A recent study published inGeriatrics & Gerontology International&nbs

Updated on: May 09,2024

Dementia may reduce likelihood of a 'good death' for patients with cancer

by WileyCredit: CC0 Public DomainAs the population ages, the number of cancer patients with dementia has increased. A recent study published inGeriatrics & Gerontology International&nbs

Updated on:May 09,2024

Alzheimer's disease and the holidays

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainThe holidays can be a special time, but may present challenges for those with dementia and their loved ones. Tra

Updated on: March 19,2024

Alzheimer's disease and the holidays

by Graciela Gutierrez,Baylor College of MedicineCredit: Unsplash/CC0 Public DomainThe holidays can be a special time, but may present challenges for those with dementia and their loved ones. Tra

Updated on:March 19,2024

Researchers study connection between cholesterol level and cognitive decline in old age

by Heidelberg UniversityChanges in lifestyle could reduce the risk of developing Alzheimer's disease. That was the conclusion of a study conducted by researchers of Heidelberg University'

Updated on: February 26,2024

Researchers study connection between cholesterol level and cognitive decline in old age

by Heidelberg UniversityChanges in lifestyle could reduce the risk of developing Alzheimer's disease. That was the conclusion of a study conducted by researchers of Heidelberg University'

Updated on:February 26,2024

A new biomarker makes it easier to distinguish between Alzheimer's and primary tauopathy

byLudwig Maximilian University of MunichDiscriminatory power of tau binding and p-tau between pairs of groups. Credit:Alzheimer's & Dementia(2024). DOI:10.1002/alz.14185. htt

Updated on: September 23,2024

A new biomarker makes it easier to distinguish between Alzheimer's and primary tauopathy

byLudwig Maximilian University of MunichDiscriminatory power of tau binding and p-tau between pairs of groups. Credit:Alzheimer's & Dementia(2024). DOI:10.1002/alz.14185. htt

Updated on:September 23,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on: April 16,2024

Alzheimer's drug trial targets toxic proteases from gum disease bacteria in the brain

by Alzheimer's Research UKP. gingivalis colonies grown on blood agar. CC0 Public DomainThe pharmaceutical company, Cortexyme, Inc. has outlined a trial of potential Alzheimer's drug that

Updated on:April 16,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on: May 06,2024

Dementia and COVID-19: Determinants of infection and mortality

by IOS PressFactors associated with 60-day mortality in dementia patients infected with SARS-CoV-2. Credit:Journal of Alzheimer's Disease(2022). DOI: 10.3233/JAD-220369The elderly

Updated on:May 06,2024